Supriya Lifescience IPO Details

Supriya Lifescience IPO Date, Price, GMP, Review, Allotment, Subscription, Analysis & Documents

About Supriya Lifescience

Supriya Lifescience is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (“APIs”), with a focus on research and development. As of October 31, 2021, Supriya Lifescience has niche product offerings of 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and antiallergic. The company has consistently been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India, contributing to 45-50% and 60-65%, respectively, of the API exports from India,
between Fiscal 2017 and 2021.

Supriya Lifescience is one of the largest exporters of Salbutamol Sulphate in India contributing to 31% of the API exports from India in FY 2021 in volume terms. The pharmaceutical business is organized into domestic and export sales, according to the geographies in which the company operate.

The customers include global pharma companies such as Syntec Do Brasil LTDA, American International Chemical Inc and AT Planejamento E Desenbolvimento De Negocios Ltda, with whom the company has business relationship for over nine years, and Suan Farma Inc, Acme Generics LLP, Akum Drugs Ltd and Mankind Pharma Ltd with whom Supriya Lifescience has business relationship for over four years.

Important Details – Supriya Lifescience

March 26, 2008The company was incorporated as ‘Supriya Lifescience Limited’

Objects of the Issue

  • Funding capital expenditure requirements of the Company;
  • Repayment and/ or pre-payment, in full or part, of certain borrowings availed by the Company and
  • General corporate purposes

Supriya Lifescience Limited Financials:

Summary of financial Information (Restated Consolidated Statement)

Particulars For the year ended (₹ in millions)
  31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 4,458.24 3,364.30 2,530.52
Total income 3,962.21 3,227.13 2,858.62
Total Expenses 2,180.70 2,132.62 2,131.01
Profit After Tax 1,238.28 734.03 394.24

Supriya IPO Details

DescriptionSupriya IPO Details
Public IssueInitial Public Issue of upto [.] equity shares of ₹ 2 (aggregating up to ₹ 7,000 million) comprising a fresh issue of upto [.] equity shares of  ₹ 2 (aggregating up to ₹ 2,000 million) and an offer of sale upto [.] equity shares  of ₹ 2 (aggregating up to ₹ 5,000 million)
Issue Open  Date16-Dec-21
Issue Close Date20-Dec-21
Issue TypeBook Building
IPO Price Band₹ 265 – ₹ 274
Face Value ₹ 2
Market Lot 54 Equity Shares and in multiples thereof
Minimum Order Quantity 54 Equity Shares
Maximum Subscription Amount for Retail InvestorRs. 2,00,000
Listing NSE, BSE
IPO Market Timings 10.00 a.m. to 5.00 p.m.

Supriya IPO DRHP & RHP

Supriya Lifescience IPO DRHP
Supriya Lifescience IPO RHP

Supriya IPO Lot Size

ApplicationLotsNo of SharesAmount (Rs)
Minimum154₹ 14,796
Maximum13702₹ 1,92,348

Supriya Lifescience IPO Lead Managers

  • ICICI Securities Limited
  • Axis Capital Limited

Supriya Lifescience IPO Registrar

Supriya Lifescience IPO Allotment Date, Listing Date and other Important Dates

Bid / Offer Opens on16-Dec-21
Bid / Offer Closes on20-Dec-21
Finalisation of Basis of Allotment23-Dec-21
Initiation of refunds 24-Dec-21
Credit of the Equity Shares27-Dec-21
Listing Date28-Dec-21

Company Peers – Comparison of Accounting Ratios

Name of CompanyFace Value EPS (Basic)
Total Income
(₹ in
NAV, as on March 31, 2021
(₹ per share)
Supriya Lifescience Limited116.923,962.2136.75
Solara Active Pharma Sciences Limited106916,457443.3
Neuland Laboratories Limited1062.859,530613
Aarti Drugs Limited 1030.0921,59398
Wanbury Limited10(5.04)3,949(62.5)
Divis Laboratories Limited274.7570,320350.10

Company Registered and Corporate Office

207/208, Udyog Bhavan,
Sonawala Road, Goregaon – East,
Mumbai – 400063,
Maharashtra, India

Company Promoters

  • Satish Waman Wagh

Supriya Lifescience IPO – FAQS

What is the Supriya Lifescience IPO Price?

The Supriya Lifescience IPO price band is ₹ 265 – ₹ 274 per share

When Supriya Lifescience IPO will open?

The Supriya Lifescience IPO opens on Dec 16, 2021 and closes on Dec 20, 2021

What is the lot size of Supriya Lifescience IPO?

The Supriya Lifescience IPO lot size is 54 Equity Shares and the minimum order quantity is 54 Equity Shares

Who is the Registrar for Supriya Lifescience IPO?

The Registrar for Supriya Lifescience IPO is Link Intime India Private Limited

How to apply in Supriya Lifescience IPO through UPI?

Check the step by step process here – Click here

How to apply in Supriya Lifescience IPO through Zerodha?

Check the step by step process here – Click here

Follow us on Telegram for all the latest updates

Related Articles


Please enter your comment!
Please enter your name here

Stay Connected

- Advertisement -spot_img

Latest Articles